191 related articles for article (PubMed ID: 33751296)
1. Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.
Lee S; Kim KW; Jeong WK; Jeong SY; Hwang JA; Choi JS; Lee SG; Joh JW
Ann Surg Oncol; 2021 Oct; 28(11):6782-6789. PubMed ID: 33751296
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5.
Shin J; Lee S; Kim SS; Chung YE; Choi JY; Park MS; Kim MJ
J Magn Reson Imaging; 2021 Nov; 54(5):1446-1454. PubMed ID: 33891790
[TBL] [Abstract][Full Text] [Related]
3. Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.
Heo S; Kang HJ; Choi SH; Kim S; Yoo Y; Choi WM; Kim SY; Lee SS
Eur Radiol; 2024 May; 34(5):2974-2985. PubMed ID: 37848775
[TBL] [Abstract][Full Text] [Related]
4. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
[TBL] [Abstract][Full Text] [Related]
5. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
7. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.
Moon JY; Min JH; Kim YK; Cha D; Hwang JA; Ko SE; Choi SY; Yun EJ; Kim SW; Won HJ
Korean J Radiol; 2021 Nov; 22(11):1786-1796. PubMed ID: 34402243
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
9. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
11. A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
Min JH; Kim JM; Kim YK; Kim H; Choi GS; Kang TW; Cha D; Hwang JA; Ko SE; Ahn S
Eur Radiol; 2022 Feb; 32(2):912-922. PubMed ID: 34345947
[TBL] [Abstract][Full Text] [Related]
12. Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis.
An C; Park S; Chung YE; Kim DY; Kim SS; Kim MJ; Choi JY
AJR Am J Roentgenol; 2017 Sep; 209(3):576-583. PubMed ID: 28657851
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of LI-RADS category on MRI in patients with primary hepatic lymphoepithelioma-like carcinoma.
Pan YJ; Liu W; Qiu QX; Miao SL; Zeng MS; Shan Y; Lin J; Xu PJ
Eur Radiol; 2023 Sep; 33(9):5993-6000. PubMed ID: 37014407
[TBL] [Abstract][Full Text] [Related]
14. LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
Choi SH; Lee SS; Park SH; Kim KM; Yu E; Park Y; Shin YM; Lee MG
Radiology; 2019 Feb; 290(2):388-397. PubMed ID: 30422088
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
Min JH; Kim SH; Hwang JA; Hyun SH; Ha SY; Choi SY; Kim SW; Kim HS
Eur Radiol; 2021 Jun; 31(6):3649-3660. PubMed ID: 33211142
[TBL] [Abstract][Full Text] [Related]
17. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
[No Abstract] [Full Text] [Related]
18. Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M.
Hu YX; Yan CJ; Yun M; Zheng W; Zou XB; Zhang YF; Mao RS; Li LL; Zhou JH
Br J Radiol; 2023 Jul; 96(1147):20220492. PubMed ID: 37066834
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
Kim SS; Lee S; Kim MJ
Eur Radiol; 2021 May; 31(5):3405-3416. PubMed ID: 33146795
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Lee S; Kim SS; Roh YH; Choi JY; Park MS; Kim MJ
Liver Int; 2020 Jun; 40(6):1488-1497. PubMed ID: 32145134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
